We are live on ! Find out more
CODX

Co-Diagnostics
CODX

8 hedge funds and large institutions have $340K invested in Co-Diagnostics in 2018 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 3

14% more funds holding

Funds holding: 7 → 8 (+1)

0.09% less ownership

Funds ownership: 1.35% → 1.26% (-0.09%)

24% less capital invested

Capital invested by funds: $450K → $340K (-$110K)

Holders
8
Holders Change
+1
Holders Change %
+14.29%
% of All Funds
0.18%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
4
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$38.1K
2
UBS Group
UBS Group
Switzerland
+$10K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$6.56K
4
HighTower Advisors
HighTower Advisors
Illinois
+$3.82K
5
BlackRock
BlackRock
New York
+$3.28K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$38K
2
OAM
Oxford Asset Management
United Kingdom
-$30K
3
TSS
Two Sigma Securities
New York
-$28K

CODX Hedge Fund Activity: Q1 2018 in Review

8 of the 4,373 institutional investors tracked by Wall St. Rank reported a position in Co-Diagnostics (CODX) for Q1 2018, worth a combined $340K — down 24% from $450K a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new CODX positions and 3 closed out — a net gain of 1 holder — while 4 added to existing stakes and 0 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $38.1K. The largest seller was Millennium Management, exiting entirely with an estimated $38K sold.

  • 8 institutional investors held Co-Diagnostics (CODX) as of Q1 2018, up from 7 in Q4 2017.
  • Funds reported $340K of Co-Diagnostics stock for Q1 2018, down 24% quarter-over-quarter.
  • 4 funds opened new Co-Diagnostics positions in Q1 2018 and 3 closed out, a net change of +1 holder.
  • The largest Co-Diagnostics buyer in Q1 2018 was Citadel Advisors, an estimated $38.1K added.
  • The largest Co-Diagnostics seller in Q1 2018 was Millennium Management, an estimated $38K sold.

Based on aggregated 13F filings for Q1 2018.